Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study (2019)

First Author: Mokry L
Attributed to:  Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.54469

Publication URI: https://www.repository.cam.ac.uk/handle/1810/307379

Type: Other